OTraces Inc. products

This highly automated testing instrument is manufactured to company specifications by Hamilton Company, producing an accurate diagnosis without human interpretation. Hamilton has been as strong supporter of OTraces, having provided all customization, programming and support at no cost, so that OTraces could transfer the immunoassay methods to the Hamilton high speed ELISA robot.

TME Liquid Biopsy Dx immunoassay test for assessing progression of low Gleason Score prostate cancer to high Gleason Score aggressive prostate cancer, Active Surveillance.

PR Sera Dx Immunoassay test panel for detection of the presence of prostate cancer and discrimination of benign prostate hyperplasia (BPH) and aggressive from non aggressive.

BC Sera Dx Immunoassay test panel for detection of the presence of breast cancer in women. In the development pipeline are an Ovarian, OV Sera Dx, and Lung, LG Sera Dx, cancer detection test kits.